Background: 18F-flortaucipir allows in-vivo visualization of tau tangles in Alzheimer's disease (AD) with a standardized definition of tau-PET positivity. However, semi-quantification is often used in research and in therapeutic trials and plays an important role in the AT(N) framework. This work aims to determine quantitative positivity thresholds and compare semi-quantification to visual interpretation.
Method: N=189 flortaucipir scans from A05 (NCT02016560) study were included (15 young-controls (YC), 48 elderly cognitively unimpaired (eCU), 85 MCIs, and 41 with AD) (Table 1), wherein the scans were visually interpreted as either T+/T-. Using a PET-only tau quantification software, volume-weighted SUVRs were calculated on Braak I-II, Braak III-IV, Braak V-VI, and temporal-meta region (TMR) (Figure 3). Three methods to calculate T+ cut-points were used: (T1) Youden-index (MCI/AD vs. Aβ- eCU), (T2) mean+2SDs of Aβ- eCU, and (T3) mean+2SDs of YC SUVRs. Using calculated cut-points, a subject is hierarchically assigned to a Braak stage if they are T+ at that stage and at all previous stages, otherwise, the subject is Braak-staging discordant.
Result: Patients characteristics and visual A+/T+ proportions are summarized in Table 1. T1-derived thresholds are: 1.26 (Braak I-II), 1.18 (Braak III-IV), 1.17 (Braak V-VI), and 1.29 (TMR) (Table 2). TMR-based T+ threshold using T2 was 1.30. Overall, the concordance of visual read with TMR-based quantification was 92%, 93%, and 88.4%, and only 8/189 (4.2%), 6/189 (3.2%), and 0% subjects were Braak staging discordant, using thresholding methods T1, T2, and T3, respectively (Figure 2b). Braak staging was associated with cognitive decline (MMSE and ADAS-Cog-11), and with increase in A+/T+ proportions. All Braak V-VI subjects had a T+ visual read. These subjects were also all Aβ+ MCI/ADs. However, 80% (8/10) of Braak III-IV, 26.9% (7/26) of Braak I-II, and 86% (44/51) of TMR+ subjects, using T1-derived thresholds, had a T+ read, whereas 95.7% (44/46) of TMR+ subjects who were also Aβ+ had a T+ read.
Conclusion: Using the temporal-meta region, visual read and SUVR were highly concordant. Visual T+ aligns more with amyloid positivity. Hierarchical Braak staging was associated with cognitive performance and amyloid load and its concordance with visual interpretation was moderate-to-high for the limbic and neocortical stages.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.084702 | DOI Listing |
Alzheimers Dement
December 2024
Laboratory of Alzheimer's Neuroimaging and Epidemiology - LANE, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Background: This study investigated microstructural features of the locus coeruleus to entorhinal cortex pathway (LC-EC) in relation to amyloid (A), tau (T), neurodegeneration (N) markers and cognitive impairment in memory clinic patients.
Method: 124 participants were recruited from the Geneva Memory Clinic (n=30 cognitively unimpaired - CU; n=80 MCI and n=14 dementia - CI) and underwent clinical assessment, 3T MRI scan including diffusion weighted imaging, amyloid PET, and tau PET. Diffusivity indices (fractional anisotropy - FA, mean, axial and radial diffusivities - MD, AxD, RD) were assessed in the LC-EC pathway using a probabilistic atlas.
Alzheimers Dement
December 2024
Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Background: The association between [F]Flortaucipir (FTP) and [F]MK6240, two commonly used tau-PET tracers in Alzheimer's disease (AD), varies due to distinct binding properties and off-target signal regions. Our study aims to elucidate the biological factors influencing this association and evaluate the applicability of a common equation across different on-target regions.
Method: 113 individuals from the HEAD dataset (11 young, 58 cognitively unimpaired elderly, and 44 cognitively impaired) underwent [F]MK6240, [F]FTP and Aβ-PET scans.
Background: Tau-PET tracers allow for in vivo Braak staging of individuals in the Alzheimer's disease (AD) continuum. The impact of tracers' characteristics for Braak staging using tau-PET remains unclear. Therefore, we performed a head-to-head comparison of Braak staging using first- and second-generation tau-PET tracers.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Institute of Neuroscience - UCLouvain, Brussels, Belgium.
Background: In AD, tauopathy and atrophy start in the mesiotemporal lobe, including the amygdala-hippocampal complex. Until recently, subnuclei and subfields within these structures were indistinguishable in-vivo. FreeSurfer 7.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of (South).
Background: We aimed to investigate whether the quantitative analysis of plasma biomarkers could distinguish the pathology stages indicated by positron emission tomography (PET)-based Thal phase of amyloid and Braak stage of tau.
Method: A total of 232 participants were enrolled, all of whom underwent F-florbetaben (FBB), F-flortaucipir (FTP) PET, plasma p-tau217/np-tau217 ratio, p-tau217, and Aβ ratio. To differentiate between image-based Thal phases and Braak stages, region-of-interests (ROIs) were constructed, and cut-off points were established at each stage using Gaussian mixture modeling.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!